Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-09-10
著者
-
谷脇 雅文
高知工科大学工学部
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Totsune Kazuhito
東北大学 臨床薬学
-
Tokunaga Katsushi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Ando Kiyoshi
Division of Hematology and Oncology, Tokai University School of Medicine
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
Takemiya Kiyoko
Department of Internal Medicine Division of Cardio-Vascular Medicine
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
Kubo Tatsuhiko
札幌医科大学 医学部公衆衛生学
-
Kondo Takaaki
Department Of Health Science Shiga University Of Medical Science
-
Kondo Takaaki
愛知医科大学 医学部公衆衛生学講座
-
Kondo Takaaki
名古屋大学 医学研究科環境病因解析学部門
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
Togitani Kazuto
Hematology Division National Cancer Center Hospital
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Graduated School Of Medicine
-
Tateishi Ukihide
Yokohama City Univ. Kanagawa Jpn
-
Tateishi Ukihide
Department Of Radiology Yokohama City University School Of Medicine
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Hospital Graduate School Of Medicine
-
Tateishi Ukihide
国立がんセンター中央病院 放射線診断部
-
Tanimoto Kazuki
国立がんセンター中央病院
-
ANDO Kiyoshi
Tokai University
-
Taniwaki Masafumi
国立がんセンター中央病院 血液内科
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Tsuchida Masahiro
産業医科大学 小児科学
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Tanimoto Mitsune
岡山大学 医歯総研究 第2内科
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
WATANABE Toru
National Cancer Center Hospital
-
Iwanaga Masako
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Iwanaga Masako
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Tsubaki Kazuo
近畿大学 産婦人科
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Tajima K
Aichi Cancer Center Research Institute
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Kondo Takahisa
名古屋大学 医学系研究科医学ネットワーク管理学
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Kuroishi Tetsuo
愛知県がんセンター研究所
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
Kuroishi Tetsuo
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute Aichi Cancer Center H
-
Tamakoshi Koji
Dep. Of Public Health - Health Information Dynamics Nagoya Univ. Graduate School Of Medicine
-
Tobinai Kensei
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Kato T
Aichi Cancer Center Hospital Nagoya Jpn
-
Taniwaki Masafumi
Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
TAKANO Kikuo
総泉病院
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeuchi Kazuhisa
Planning For Drug Development And Clinical Evaluation Tohoku University Graduate School Of Pharmaceu
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Tanaka Keitaro
Department Of Preventive Medicine Faculty Of Medicine Saga University
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Matsuo Yuji
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Takagi Kenzo
Third Division Of The Research Laboratory For Development Of Medicine School Of Pharmacy Hokuriku Un
-
Taniwaki Masafumi
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Watanabe T
Tokyo Univ. Tokyo
-
Kinoshita Tomohiro
Mie University
-
Tobinai Kensei
National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Masaki Y
Department Of Hematology And Immunology Kanazawa Medical University
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Watanabe Toru
Hematology Division National Cancer Center Hospital
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Morita Yasuyoshi
Kinki Univ. School Of Medicine Osaka Jpn
-
Takagi K
Department Of Public Health Miyazaki Medical College University Of Miyazaki
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Watanabe T
Department Of Pathology Gifu University School Of Medicine
-
Taniwaki Masafumi
Department Of Clinical Molecular Genetics And Laboratory Medicine Kyoto Prefectural University Of Me
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Omachi Ken
Department Of Hematology And Oncology Tokai University School Of Medicine
-
Kikuchi Ako
Tokai University
-
Ochi Kensuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Koshikawa Takashi
Department Of Clinical Laboratory Aichi Cancer Center Hosprtal
-
Toda Katsuhisa
First Department Of Internal Medicine Gifu University School Of Medicine
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Yasukawa Masaki
Department Of Bioregulatory Medicine Ehime University
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Miki Yoshio
Department Of Human Genome Analysis Cancer Chemotherapy Center Japanese Foundation For Cancer Resear
-
TAKAHASHI Kazuhiro
Saga Prefectural Hospital
-
Tanimoto Mitsune
Okayama Univ. Graduate School Of Medicine Okayama Jpn
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kato Tomohiro
Aichi Cancer Center Hospital Nagoya Jpn
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
OHMACHI Ken
Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicin
-
Takeda Kazunori
Department Of Preventive Medicine And Community Health School Of Medicine University Of Occupational
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Tabata Masahiro
The Department Of Internal Medicine Ii Okayama University Medical School
-
Watanabe Toru
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Matsumoto Yosuke
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Kosaka Takayuki
Department Of Thoracic Surgery Aichi Cancer Center Research Institute
-
Tokunaga Katsushi
Department Of Endocrinology And Applied Medical Science Tohoku University Graduate School Of Medicin
-
Uchida Toshiki
Department Of Hematology And Oncology Nagoya Daini Red Cross Hospital
-
Totsune Kazuhito
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
Mikami Yuzuru
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
TATEISHI Ukihide
Department of Radiology, Yokohama City University Graduate School of Medicine
-
Matsumoto Yosuke
Department of Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science
関連論文
- ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
- P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
- PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
- SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
- 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
- マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
- SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
- PS-095-1 n0乳癌における再発予後予測システムの検討
- SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
- 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
- PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
- イオン注入法によるFe及びCu超微粒子形成とGMR特性(第17回「電磁力関連のダイナミクス」シンポジウム)
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
- 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
- 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
- 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
- SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
- がんの遺伝解析 (特集 ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
- 大腸癌表層部と先進部の発現プロファイル解析
- IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
- 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
- SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
- O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
- 点欠陥の自己組織化的挙動を利用した微細構造形成法
- イオン照射で導入される点欠陥を利用したナノセル構造の形成
- イオン照射によって導入された点欠陥によるセル構造の形成
- イオン照射による半導体微細セル構造の自己組織化形成
- 低温でのSnイオン注入によってGaSb表面に形成される特異な欠陥構造とその形成機構
- DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
- AuCu合金の相転移と熱膨張挙動
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- 乳がんのLarge-scale genomic study
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
- Successful cord blood transplantation for mycosis fungoides.
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Identifying haplotype block structure using an ancestor-derived model
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
- Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
- Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
- Clinicopathological Features of Hereditary Breast Cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Identification of Rad51 alteration in patients with bilateral breast cancer
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
- 白滝鉱山が地域にもたらしたもの
- 「わが国の鉱業の過去, 現在そして未来」の企画にあたって
- 小特集の企画にあたって
- Void Formation and Structure Change Induced by Heavy Ion Irradiation in GaSb and InSb
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Formation of Defect Structure on Ge Surface by Ion Irradiation at Controlled Substrate Temperature
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Intravascular B-cell lymphoma with hypercalcemia as the initial presentation
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes